Abstract:With the rapid rise in gene-editing technology, pluripotent stem cells (PSCs) and their derived organoids have increasingly broader and practical applications in regenerative medicine. Gene-editing technologies, from large-scale nucleic acid endonucleases to CRISPR, have ignited a global research and development boom with significant implications in regenerative medicine. The development of regenerative medicine technologies, regardless of whether it is PSCs or gene editing, is consistently met with controversy. Are the tools for rewriting the code of life a boon to humanity or a Pandora's box? These technologies raise concerns regarding ethical issues, unexpected mutations, viral infection, etc. These concerns remain even as new treatments emerge. However, the potential negatives cannot obscure the virtues of PSC gene editing, which have, and will continue to, benefit mankind at an unprecedented rate. Here, we briefly introduce current gene-editing technology and its application in PSCs and their derived organoids, while addressing ethical concerns and safety risks and discussing the latest progress in PSC gene editing. Gene editing in PSCs creates visualized in vitro models, providing opportunities for examining mechanisms of known and unknown mutations and offering new possibilities for the treatment of cancer, genetic diseases, and other serious or refractory disorders. From model construction to treatment exploration, the important role of PSCs combined with gene editing in basic and clinical medicine studies is illustrated. The applications, characteristics, and existing challenges are summarized in combination with our lab experiences in this field in an effort to help gene-editing technology better serve humans in a regulated manner. Current preclinical and clinical trials have demonstrated initial safety and efficacy of PSC gene editing; however, for better application in clinical settings, additional investigation is warranted.

Paving the Road for Biomedicine: Genome Editing and Stem Cells in Primates

CRISPR/Cas9-mediated genome editing in nonhuman primates

Primate Stem Cells: Bridge the Translation from Basic Research to Clinic Application

[Applications of ZFN, TALEN and CRISPR/Cas9 Techniques in Disease Modeling and Gene Therapy].

Embryo-Engineered Nonhuman Primate Models: Progress and Gap to Translational Medicine

CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection

Opportunities and challenges in modeling human brain disorders in transgenic primates

A piggyBac-based platform for genome editing and clonal rhesus macaque iPSC line derivation

Opportunities and limitations of genetically modified nonhuman primate models for neuroscience research

Targeted Genome Editing in Primate Embryos

Primate Primordial Germ Cells Acquire Transplantation Potential by Carnegie Stage 23

Chimpanzee and Pig-Tailed Macaque Ipscs: Improved Culture and Generation of Primate Cross-Species Embryos.

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

In vivo whole brain, cellular and molecular imaging in nonhuman primate models of neuropathology

Gene Editing in Pluripotent Stem Cells and Their Derived Organoids

Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver

Non-human Primate Models for Brain Disorders – Towards Genetic Manipulations Via Innovative Technology

Update on Hematopoietic Stem Cell Gene Transfer Using Non-Human Primate Models.

Gene Delivery to Nonhuman Primate Preimplantation Embryos Using Recombinant Adeno-Associated Virus.

The Long-Term Survival and Functional Maturation of Human Inpc-Derived Neurons in the Basal Forebrain of Cynomolgus Monkeys

Primate cell fusion disentangles gene regulatory divergence in neurodevelopment